新型冠状病毒病(COVID-19)疫情期间恶性肿瘤高剂量率近距离治疗推荐

Recommendations on high-dose-rate rachytherapy for malignant tumors during COVID-19 epidemic

目前国内新型冠状病毒病疫情总体呈现散发状态,防范疫情任务仍然艰巨。近距离治疗(BT)在肿瘤患者治疗中起着重要的作用,在部分恶性肿瘤放疗过程中,BT不能被替代也不可过度延迟。而对于疫情期间BT推荐或指导的相关报道较少。本文总结国内外可检索到的较少几篇关于疫情期间BT的推荐,结合吉林大学中日联谊医院放射治疗科在前期疫情期间的工作经验,希望可以给同行们提供疫情期间恶性肿瘤高剂量率BT的参考。

InChina,COVID-19 epidemic is currently showing a sporadic state,and the task of epidemic prevention is still arduous.Brachytherapy(BT)plays a critical role in the treatment of cancer.For some cancer receiving radiotherapy,use of BT can not be replaced or excessively delayed.Nevertheless,the recommendations or guidelines regarding the application of BT during COVID-19 epidemic have been rarely reported.In this article,a few recommendations on the application of BT during COVID-19 epidemic were retrieved and the work experience of Department of Radiation Oncology,China-Japan Union Hospital of Jilin University in the early epidemic period was summarized,aiming to provide relevant reference for the use of high-dose-rate BT for malignant tumor patients during COVID-19 epidemic.